FDA 在信中引用了长期安全数据的“突出问题”。然而,Nymox 声称,在 3 月份提交申请之前,该机构在其任何一次交流中...查看全文
产业链观察2022-05-24 18:03
药闻▶2022年5月23日,$耐莫斯制药(NYMX)$ 今天报告说,它已于美国东部时间5月20日星期五下午2:48收到FDA关于公司的Fexapotide Triflutate新药申请("NDA")的拒绝提交("RTF")信。
Nymox的立场是,澄清问题仍需在后续会议上解决,并涉及一些重大的不一致之处。...查看全文
$Nymox Pharmaceutical(NYMX)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2015-11-25 AccNo: 0001176256-15-000362 Size: 172 KB 网页链接
$Nymox Pharmaceutical(NYMX)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2015-11-23 AccNo: 0001176256-15-000358 Size: 16 KB 网页链接
$Nymox Pharmaceutical(NYMX)$ UPLOAD [Cover] - SEC-generated letter Filed: 2015-07-24 AccNo: 0000000000-15-038421 Size: 156 KB 网页链接
$Nymox Pharmaceutical(NYMX)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2015-08-27 AccNo: 0001651844-15-000001 Size: 6 KB 网页链接
$Nymox Pharmaceutical(NYMX)$ F-3/A [Amend][Cover] - Registration statement by foreign private issuers Filed: 2015-07-24 AccNo: 0001176256-15-000260 Size: 413 KB 网页链接
$Nymox Pharmaceutical(NYMX)$ EFFECT - Notice of Effectiveness Filed: 2015-08-04 AccNo: 9999999995-15-002173 Size: 1 KB 网页链接
$Nymox Pharmaceutical(NYMX)$ CORRESP [Cover] - Correspondence Filed: 2015-08-04 AccNo: 0001176256-15-000268 Size: 5 KB 网页链接
$Nymox Pharmaceutical(NYMX)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2015-08-24 AccNo: 0001176256-15-000293 Size: 453 KB 网页链接
$Nymox Pharmaceutical(NYMX)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2015-08-07 AccNo: 0001176256-15-000278 Size: 8 KB 网页链接
$Nymox Pharmaceutical(NYMX)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2015-07-28 AccNo: 0001176256-15-000264 Size: 6 KB 网页链接